Molecular Allergy Diagnostics as an Adjunct to Conventional Diagnostics in a Secondary Pediatric Referral Center

Author(s): Ole D. Wolthers*.

Journal Name: Recent Patents on Inflammation & Allergy Drug Discovery

Volume 13 , Issue 1 , 2019

Become EABM
Become Reviewer

Abstract:

Background: Several compositions for determination of specific molecular components in allergens have recently been patented. The role of Molecular Allergy (MA) diagnostics in suspected IgE mediated allergic conditions is currently debated. Guideline reports have concluded that population- based studies involving evaluation of the usefulness of MA diagnostics are needed.

Objective: To evaluate the usefulness of MA diagnostics in a secondary pediatric referral center.

Methods: A total of 961 children and adolescents aged 0.2-18.8 (mean 7.0) years was included in a prospective observational survey. Inclusion criterion was a suspected diagnosis of an IgE mediated condition based on history and clinical symptoms and signs. If a specific diagnosis could not be reached from conventional investigations suspected peanut allergy, birch pollen allergy and associated crossreactivity, insect allergy and triggering allergens for specific immunotherapy were assessed by MA diagnostics.

Results: Based on conventional work-up a diagnostic conclusion was established in 946 patients (98.4%). MA diagnostics were performed in 15 individuals (1.6%), 7 girls and 8 boys aged 3.2 to 17.8 (mean 10.6) years. In 8 cases a specific diagnosis was established based on MA diagnostics; in 7 cases MA diagnostics could not improve diagnosis. MA were most frequently (N = 7 (14%)) used in children with peanut allergy (N = 50).

Conclusion: Most patients in a secondary pediatric referral center with suspected IgE mediated allergy can be managed by conventional diagnostic methods. MA diagnostics may be useful in small and selected subgroups as in patients with suspected peanut allergy, however, may not be helpful in all cases.

Keywords: Allergy, asthma, component resolved diagnosis, eczema, molecular allergy diagnostics, peanut, rhinitis, urticaria.

[1]
Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hoffmaier S, et al. EAACI Molecular Allergology User’s Guide. PAI. 2016; (S23): pp. 1-250.
[http://dx.doi.org/http://dx.doi.org/10.1111/pai.12563]
[2]
Canonica GW, Ansotegui IJ, Pawankar R, et al. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 2013; 6(1): 17.
[http://dx.doi.org/http://dx.doi.org/10.1186/1939-4551-6-17] [PMID: 24090398]
[3]
Kennedy GC, Chudova DI, Wang ET, Wilde JT. Algorithms for disease diagnostics. US20180127832 2018.
[4]
Valenta R, Campana R, Mothes-luksch N. Method for determining the type of allergy. EP2078960 2009.
[5]
Sampson HA. Prognostic allergy test. EP1939628 2017.
[6]
Borres MP, Ebisawa M, Eigenmann PA. Use of allergen components begins a new era in pediatric allergology. Pediatr Allergy Immunol 2011; 22(5): 454-61.
[7]
Wolthers OD. Resolved component diagnostics in pediatrics. ISRN Pediatr 2012.
[http://dx.doi.org/http://dx.doi.org/10.5420/2012/806920]
[8]
Jensen-Jarolim E, Jensen AN, Canonica GW. Debates in allergy medicine: Molecular allergy diagnosis with ISAX will replace screenings by skin prick test in the future. World Allergy Organ J 2017; 10(1): 33.
[http://dx.doi.org/http://dx.doi.org/10.1186/s40413-017-0162-3] [PMID: 28959378]
[9]
Gradman J, Wolthers OD. Allergic conjunctivitis in children with asthma, rhinitis and eczema in a secondary outpatient clinic. Pediatr Allergy Immunol 2006; 17(7): 524-6.
[http://dx.doi.org/http://dx.doi.org/10.1111/j.1399-3038.2006.00429.x] [PMID: 17014628]
[10]
Ewan PW, Coote D. Evaluation of a capsulated hydrophilic carrier polymer (the immunoCAP) for measurement of specific Ig antibodies. Allergy 1990; 45(1): 22-9.
[http://dx.doi.org/http://dx.doi.org/10.1111/j.1398-9995.1990.tb01080.x] [PMID: 2309986]
[11]
Yman L. Standardization of in vitro methods. Allergy 2001; 56(Suppl. 67): 70-4.
[http://dx.doi.org/http://dx.doi.org/10.1111/j.1398-9995.2001.00921.x] [PMID: 11298014]
[12]
Oppenheimer J, Durham S, Nelson H, Wolthers OD. Allergy Diagnostic Testing. WAO, WAO 2014 July;. http://www.worldallergy.org/ professional/allergic_diseases_center/allergy_diagnostic/ [Accessed November 24 2017]
[13]
Lindvik H, Lødrup Carlsen KC, Mowinckel P, Navaratnam J, Borres MP, Carlsen KH. Conjunctival provocation test in diagnosis of peanut allergy in children. Clin Exp Allergy 2017; 47(6): 785-94.
[http://dx.doi.org/http://dx.doi.org/10.1111/cea.12899] [PMID: 28160326]
[14]
R Core Team. R: A Language and Environment for Statistical Computing 2017.https://www.r-project.org/
[15]
Skamstrup Hansen K, Poulsen LK. Component resolved testing for allergic sensitization. Curr Allergy Asthma Rep 2010; 10(5): 340-8.
[http://dx.doi.org/http://dx.doi.org/10.1007/s11882-010-0133-z] [PMID: 20628838]
[16]
Masthoff LJN, Blom WM, Rubingh CM, Klemans RJB, Remington BC, Bruijnzeel-Koomen CAFM, et al. Sensitization to Cor a 9 or Cor a 14 has a strong impact on the distribution of thresholds to hazelnut. J Allergy Clin Immunol Pract 2018; 6(6): 2112-2114.e1.
[http://dx.doi.org/http://dx.doi.org/10.1016/j.jaip.2018.04.040] [PMID: 29782938]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 1
Year: 2019
Page: [73 - 76]
Pages: 4
DOI: 10.2174/1872213X13666190610143439

Article Metrics

PDF: 14
HTML: 3
EPUB: 1
PRC: 1